Author(s): Balasundaram S, Ranganathan K, Umadevi K, Gunaseelan R, Kumaraswamy N,
Abstract Share this page
Abstract Nevirapine is a non-nucleoside reverse transcriptase inhibitor, widely used in combination with other antiretroviral agents for treatment of HIV infection. Steven Johnson syndrome (SJS) is the major toxicity of nevirapine. We describe here four cases of SJS in HIV seropositive patients following nevirapine therapy. In all four cases cutaneous hypersensitivity reaction was seen with extreme oral lesions, three patients presented clinically with elevated liver enzymes and hepatitis, and two patients had ocular involvement.
This article was published in J Oral Maxillofac Pathol
and referenced in Journal of AIDS & Clinical Research